search
Back to results

Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial (COMFORT)

Primary Purpose

Hypertension

Status
Completed
Phase
Phase 3
Locations
Japan
Study Type
Interventional
Intervention
Combination pill of losartan and hydrochlorothiazide
Sponsored by
Kyushu University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring Hypertension, combination pill, compliance

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 20 years or above
  • Hypertension defined as blood pressure levels of >/=140/90mmHg or current use of blood pressure lowering drugs
  • Able to commence combination therapy of angiotensin receptor antagonists and diuretics

Exclusion Criteria:

  • Blood pressure measurements of >/=200/120mmHg
  • Previous serious adverse events due to angiotensin receptor antagonists or diuretics
  • Known or possible pregnancy
  • Known severe liver dysfunction
  • Known severe kidney disease
  • Known contraindication to angiotensin receptor antagonists or diuretics
  • Taking >/=4 tablets except for angiotensin receptor antagonists
  • ACE inhibitors, thiazide or thiazide-like diuretics in the morning
  • Current participation in another clinical trial
  • A high likelihood that the patient is not suitable for the study treatment

Sites / Locations

  • Department of Medicine and Clinical Science, Kyushu University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Combination pill

Control group

Arm Description

Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning

combination therapy of angiotensin receptor antagonists (losartan potassium 50mg, candesartan 8mg, valsartan 80mg, telmisartan 40mg or olmesartan 20mg) and thiazide or thiazide-like diuretics (hydrochlorothiazide 6.25-12.5mg, trichlormethiazide 0.5-1.0mg, indapamide 0.5-1.0mg or chlorthalidone 6.25-12.5mg)

Outcomes

Primary Outcome Measures

Medication compliance

Secondary Outcome Measures

Blood pressure
cost of blood pressure lowering drugs
serious adverse events
adverse events
blood test

Full Information

First Posted
April 30, 2008
Last Updated
March 4, 2011
Sponsor
Kyushu University
search

1. Study Identification

Unique Protocol Identification Number
NCT00670787
Brief Title
Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial
Acronym
COMFORT
Official Title
A Randomized Trial to Establish the Effects of Combination Pill of Losartan Potassium and Hydrochlorothiazide on Medication Compliance Among Patients With High Blood Pressure.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2011
Overall Recruitment Status
Completed
Study Start Date
June 2008 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
February 2011 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Kyushu University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the study is to determine whether combination pill of losartan potassium and hydrochlorothiazide will improve medication compliance among patients with high blood pressure.
Detailed Description
Despite clear evidence that blood pressure lowering treatment is beneficial for reduction of cardiovascular disease, blood pressure levels are not adequately controlled in many hypertensive patients. More intensive blood pressure lowering treatment is required to achieve maximum reduction of cardiovascular disease. Combination pills of blood pressure lowering drugs could be a safe and effective strategy to achieve blood pressure target but there is no randomized evidence that established the beneficial effects of combination pills of blood pressure lowering drugs. The purpose of the study is to determine whether combination pill of losartan potassium and hydrochlorothiazide will improve medication compliance among patients with high blood pressure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Hypertension, combination pill, compliance

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
207 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Combination pill
Arm Type
Active Comparator
Arm Description
Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning
Arm Title
Control group
Arm Type
No Intervention
Arm Description
combination therapy of angiotensin receptor antagonists (losartan potassium 50mg, candesartan 8mg, valsartan 80mg, telmisartan 40mg or olmesartan 20mg) and thiazide or thiazide-like diuretics (hydrochlorothiazide 6.25-12.5mg, trichlormethiazide 0.5-1.0mg, indapamide 0.5-1.0mg or chlorthalidone 6.25-12.5mg)
Intervention Type
Drug
Intervention Name(s)
Combination pill of losartan and hydrochlorothiazide
Other Intervention Name(s)
Preminent
Intervention Description
Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning
Primary Outcome Measure Information:
Title
Medication compliance
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Blood pressure
Time Frame
6 months
Title
cost of blood pressure lowering drugs
Time Frame
6 months
Title
serious adverse events
Time Frame
6 months
Title
adverse events
Time Frame
6 months
Title
blood test
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 20 years or above Hypertension defined as blood pressure levels of >/=140/90mmHg or current use of blood pressure lowering drugs Able to commence combination therapy of angiotensin receptor antagonists and diuretics Exclusion Criteria: Blood pressure measurements of >/=200/120mmHg Previous serious adverse events due to angiotensin receptor antagonists or diuretics Known or possible pregnancy Known severe liver dysfunction Known severe kidney disease Known contraindication to angiotensin receptor antagonists or diuretics Taking >/=4 tablets except for angiotensin receptor antagonists ACE inhibitors, thiazide or thiazide-like diuretics in the morning Current participation in another clinical trial A high likelihood that the patient is not suitable for the study treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kiyoshi Matsumura, MD PhD
Organizational Affiliation
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Medicine and Clinical Science, Kyushu University
City
Fukuoka City
State/Province
Fukuoka
ZIP/Postal Code
812-8582
Country
Japan

12. IPD Sharing Statement

Learn more about this trial

Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

We'll reach out to this number within 24 hrs